Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Enanthate for Pelvic Floor Muscles in Postmenopausal Women
NCT04026880Phase 3Withdrawn
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of testosterone enanthate in urinary incontinence (UI), sponsored by Brigham and Women's Hospital. Planned start Jan 2021; status: withdrawn.
02
Drugs
testosterone enanthate
03
Conditions
urinary incontinence (UI)
Beyond the preview
Go deeper on NCT04026880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04026880.